SEC Form 4 · accession 0001209191-15-062021
CORCEPT THERAPEUTICS INC · CORT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Daniel Bradbury
Director
Period of report
Jul 20, 2015
Accepted (ET)
Jul 22, 2015 · 2:26 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001088856
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common stockF1 | Jul 20, 2015 | S | 10,000 | $5.32 | D | 287,925 | I | BioBrit, LLC. |
| Common stockF2 | Jul 21, 2015 | S | 10,000 | $4.98 | D | 277,925 | I | BioBrit, LLC. |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents the weighted average sale price for the entire number of shares sold. The sale prcies ranged from $5.13 to $5.57 per share.
- F2Represents the weighted average sale price for the entire number of shares sold. The sale prcies ranged from $4.80 to $5.20 per share.